Sankaranarayanan, R.A.; Peil, J.; Vogg, A.T.J.; Bolm, C.; Terhorst, S.; Classen, A.; Bauwens, M.; Maurer, J.; Mottaghy, F.; Morgenroth, A.
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230. Cancers 2023, 15, 2641.
https://doi.org/10.3390/cancers15092641
AMA Style
Sankaranarayanan RA, Peil J, Vogg ATJ, Bolm C, Terhorst S, Classen A, Bauwens M, Maurer J, Mottaghy F, Morgenroth A.
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230. Cancers. 2023; 15(9):2641.
https://doi.org/10.3390/cancers15092641
Chicago/Turabian Style
Sankaranarayanan, Ramya Ambur, Jennifer Peil, Andreas T. J. Vogg, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Jochen Maurer, Felix Mottaghy, and Agnieszka Morgenroth.
2023. "Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230" Cancers 15, no. 9: 2641.
https://doi.org/10.3390/cancers15092641
APA Style
Sankaranarayanan, R. A., Peil, J., Vogg, A. T. J., Bolm, C., Terhorst, S., Classen, A., Bauwens, M., Maurer, J., Mottaghy, F., & Morgenroth, A.
(2023). Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230. Cancers, 15(9), 2641.
https://doi.org/10.3390/cancers15092641
